LATEST STORIES:

Drug test for artery meds in Hamilton

Make us a preferred source on Google
Share this story...

Hamilton’s Population Health Research Institute and “Bayer Incorporated” are teaming up to carry out a major worldwide trial of a new medication for artery disease.

The study, nicknamed “Compass,” will investigate whether a certain type of oral medication can help reduce heart attacks, stroke and cardiovascular deaths.

The trial will involve 20,000 patients suffering from artery disease.

It’s expected to run for several years.